ArticleSignal transduction and targeted therapy2026

Phase 1 pilot study for hemophilia-A: AAV8 vector with prophylactic tacrolimus-glucocorticoid achieves therapeutic FVIII activity.

Wei Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.